Evidence map›Paper›PMID 34316574›Full record

ArticleInfection prevention in practice2021

An outbreak of carbapenem-resistant

Tamar Gottesman, Rina Fedorowsky, Rebecca Yerushalmi, Jonathan Lellouche, Amir Nutman

Abstract read
In one paragraph

Article in Infection prevention in practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Carbapenem-resistantFrontiers in medicine · 2026
    Article
  5. Article
  6. Antimicrobial agents and chemotherapy · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Multidrug resistantCurrent research in microbial sciences · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Viruses · 2024
    Review
  16. Review
  17. Article
  18. Treatment and Management ofInfection and drug resistance · 2024
    Review
  19. Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tamar GottesmanInfectious Diseases and Control Unit, Rabin Medical Center, Hasharon Hospital, Petach Tikva, Israel.
Rina FedorowskyInfectious Diseases and Control Unit, Rabin Medical Center, Hasharon Hospital, Petach Tikva, Israel.
Rebecca YerushalmiMicrobiology Laboratory, Rabin Medical Center, Hasharon Hospital, Petach Tikva, Israel.
Jonathan LelloucheNational Institute for Infection Control and Antibiotic Resistance, Israel Ministry of Health, Israel.
Amir NutmanSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe an outbreak of carbapenem-resistant

Indexed as

Carbapenem-resistant Acinetobacter baumannii (CRAB)COVID-19 pandemicEnvironmental samplingInfection controlOutbreak investigationScreening

Identifiers

PMID34316574
PMCPMC7794049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.